Compare BZAI & KRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BZAI | KRMD |
|---|---|---|
| Founded | 2010 | 1980 |
| Country | United States | United States |
| Employees | 254 | N/A |
| Industry | | Medical/Dental Instruments |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 236.9M | 195.7M |
| IPO Year | N/A | 2019 |
| Metric | BZAI | KRMD |
|---|---|---|
| Price | $1.76 | $4.30 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 4 |
| Target Price | $5.50 | ★ $6.50 |
| AVG Volume (30 Days) | ★ 7.3M | 145.2K |
| Earning Date | 05-13-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 53.85 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $41,127,366.00 |
| Revenue This Year | $239.02 | $20.32 |
| Revenue Next Year | $46.03 | $17.37 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 22.23 |
| 52 Week Low | $1.00 | $2.08 |
| 52 Week High | $6.76 | $6.61 |
| Indicator | BZAI | KRMD |
|---|---|---|
| Relative Strength Index (RSI) | 54.32 | 45.73 |
| Support Level | $1.03 | $4.08 |
| Resistance Level | $2.40 | $4.34 |
| Average True Range (ATR) | 0.29 | 0.20 |
| MACD | 0.03 | 0.03 |
| Stochastic Oscillator | 47.49 | 63.83 |
Blaize Holdings Inc provides transformative artificial intelligence (AI)-enabled edge computing solutions comprised of both its proprietary hardware and software, and third-party hardware solutions. Its portfolio includes programmable AI processors in various form factors, which can be deployed across sectors such as smart cities, defense, retail, and enterprise markets. The company operates as a single operating and reportable segment. The majority of the company's revenue is derived from Hardware revenue, which includes the sale of its semiconductor products and/or third-party hardware products that support semiconductor products through various supply agreements. Geographically, it generates the maximum revenue from China.
KORU Medical Systems Inc develops, manufactures, and commercializes large volume subcutaneous infusion solutions for the subcutaneous drug delivery market. Its product portfolio focuses on mechanical infusion devices, including the FREEDOM60 and FreedomEdge syringe drivers, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing. The company operates as one segment. Its revenue streams are: Domestic Core, International Core and Pharma services and clinical trials. The majority of the company's revenue is derived from the Domestic Core business, which consists of sales of its syringe drivers, tubing and needles. Geographically, its revenues are predominantly derived from the United States.